APR 29, 2016 11:39 AM PDT

3D NuRD Complex Related to Cancer Progression

WRITTEN BY: Kara Marker
When the equilibrium of gene regulation is disrupted, whether by random mutation, ultraviolet light exposure, or another cause, the risk of abnormal cell division and tumor growth drastically increases. A new study from the University of Leicester describes a way to restore equilibrium and reduce incidence of genetic diseases.
 
MTA1, RBBP4, and HDAC1 are core protein components of a complex called NuRD, which is responsible for regulating the amount of protein made from transcription and translation processes. When these core proteins’ interactions are inhibited or communication is misconstrued, the complex falls out of equilibrium and diseases can sprout and progress.
 
The NuRD Complex

NuRD regulates gene expression through the control and maintenance of chromatin, the genetic material that forms chromosomes inside eukaryotic cell nuclei (Nature). Chromatin allows for DNA to be organized into tightly-wound complexes called histones, which then form nucleosomes. This highly-ordered structure is dependent on consistency and accuracy, so when one brick is out of place, the whole system struggles to function properly.
 
In hopes to both understand the three-dimensional structure of the NuRD complex proteins as well as characterize their molecular nature, University of Leicester researchers studied images using electron microscopy. Their results were recently published in the journal eLIFE.
 
HDAC1 and MTA1 are known to exist at high levels in some incidences of cancer, and studying the interaction between these proteins as well as the relationship between MTA1 and RBBP4 in cancer patients and healthy patients could give the researchers a clue on how to protect disease-preventing equilibrium.
 
Electron microscopy showed an “extensive interface” between MTA1 and RBBP4. The three-dimensional images also showed a “repression complex” in cases where equilibrium was disrupted from NuRD complex-related activity. Specifically, the findings showed a second recruitment site within MTA1 for RBBP4, not known to exist before this study. Based on the different combinations of conformations between the three core proteins, the complexes are able to bind to different histones at different times. Understanding the components of this repression complex and the entire “architecture” of the NuRD complex will help scientists identify which mechanisms they should be targeting as a treatment option.
 
“An understanding [of] the exact mechanism by which the NuRD complex assembles and functions could make it an attractive target for developing novel and specific anti-cancer therapeutics and treatment for a range of genetic diseases,” said University of Leicester’s Dr. Christopher Millard.
 
Now that the University of Leicester research team has developed a more complete model of the NuRD complex, they can move on to understanding what goes wrong in NuRD signaling in cases of cancer or genetic diseases.
 
 
Sources: University of Leister, eLIFE
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 08, 2021
Microbiology
Fecal Transplants May Improve Cancer Treatment Efficacy
FEB 08, 2021
Fecal Transplants May Improve Cancer Treatment Efficacy
Humans carry around trillions of microbes, and the ones in our guts - the gut microbiome - plays an essential role in ou ...
MAR 11, 2021
Cell & Molecular Biology
Deadly Cancer Cells Can Move in the Wrong Direction
MAR 11, 2021
Deadly Cancer Cells Can Move in the Wrong Direction
Cancer is most deadly when it metastasizes; when cells break away from a primary site of cancer and move through the bod ...
MAR 22, 2021
Cancer
Can we use our own bacteria to fight cancer?
MAR 22, 2021
Can we use our own bacteria to fight cancer?
New research highlighted recently in Nature explores the ways that bacteria in tumors could be targeted to trigger immun ...
APR 06, 2021
Immunology
Lymphoma Patient Cured by "Reeducating" their Immune System
APR 06, 2021
Lymphoma Patient Cured by "Reeducating" their Immune System
Australian researchers have used a breakthrough therapy to cure a patient diagnosed with a rare brain lymphoma, a form o ...
APR 11, 2021
Genetics & Genomics
Trial Shows Personalized Cancer Vaccines are Safe
APR 11, 2021
Trial Shows Personalized Cancer Vaccines are Safe
Vaccines are mostly known as tools to prevent illness. But cancer vaccines are a bit different, and aim to treat existin ...
APR 14, 2021
Cancer
Cell Viability- Where to Begin?
APR 14, 2021
Cell Viability- Where to Begin?
Written By: Author As I pondered the title of this article, my thoughts immediately went back to a request by my Ph.D. a ...
Loading Comments...